CURLF CURALEAF HOLDINGS INC
- 5.290
- -0.300-5.37%
CURALEAF HOLDINGS INC News
Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to t
Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
Four lesser-valued cannabis stocks showed positive performance on Monday, defying the broader sector's downtrend. These stocks—Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms Int
Bearish Monday For Marijuana Stocks - Flower One Hldgs, SOL Glb Inv Among Top Gainers
GAINERS:Heritage Cannabis Holding (OTC:HERTF) shares closed up 63.64% at $0.001933 Industries (OTC:TGIFF) shares closed up 27.70% at $0.01Target Group (OTC:CBDY) shares closed up 19.19% at $0.01Rocky
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. B
DoJ Proposed Cannabis Rescheduling Rule Says DEA Still Hasn't Weighed in
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Significant tax benefits are anticipated for the cannabis industry, following President Joe Biden's confirmation of the administration's intent to reschedule cannabis from Schedule I to Schedule III.
Biden Announces 'Monumental' Marijuana Rescheduling, DOJ To Take Next Steps
President Joe Biden announced on Thursday that his administration is officially moving to reschedule marijuana under federal law, while praising what he called a "monumental" step."Today my administra
Market Chatter: Justice Department Set to Post Cannabis Reclassification Plans
The US Department of Justice is planning to issue a notice of proposed rulemaking Thursday that would reclassify marijuana to a less-restrictive category, Politico reported, citing two Biden administr
Largest Cannabis Co. Curaleaf's $1.5B Projected Revenue For 2025: Analyst Raises Rating To Outperform
Wedbush Securities released a report on Curaleaf Holdings, Inc. (OTC:CURLF), the largest U.S. cannabis company by market cap, raising the stock's 12-month price target to $7.00 from $6.00 and maintain
Florida Cannabis Legalization Amendment Ads Hit Airwaves: The First 4 Pitches For Legal Weed In The Sunshine State
Smart and Safe Florida, the group behind Florida's ballot measure to legalize marijuana for recreational use, is hitting the TV screens and airwaves across the Sunshine State with four campaign ads to
Cannabis Shops Could Launch This Year In Germany For 'Scientific Purposes,' Here's Why UK's Medical Marijuana Sales Are Soaring
Over the last several years, Europe has become more open-minded about medical and recreational marijuana. Here are some of the latest cannabis developments from the United Kingdom and Germany. Germany
Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials
A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legislative changes on its operations. Concurrently, Needham's report highlights Tru
CURALEAF HOLDINGS INC | 6-K: Report of foreign private issuer (related to financial reporting)
Curaleaf Looks to Follow Trulieve's Tax-Slashing Strategy
By Dean Seal Curaleaf Holdings tentatively plans to claim it isn't subject to a burdensome tax code that has sapped the cannabis industry's profits for years, following in the footsteps of a rival th
Needham: Maintaining the Curaleaf Holdings (CURLF.US) rating, adjusted from buy to buy rating, and adjusted the target price from $5.25 to $6.25.
Needham: Maintaining the Curaleaf Holdings (CURLF.US) rating, adjusted from buy to buy rating, and adjusted the target price from $5.25 to $6.25.
Needham Maintains Buy on Curaleaf Holdings, Raises Price Target to $6.25
Needham analyst Matt McGinley maintains Curaleaf Holdings (OTC:CURLF) with a Buy and raises the price target from $5.25 to $6.25.
Curaleaf Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 13.64% Needham $5.25 → $6.25 Maintains Buy 03/08/2024 9.09% Wedbush $4.5 → $6 Maintains Outperf
Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion
Curaleaf Holdings, Inc. (OTC:CURLF), a leading international cannabis company, reported its financial results for the first quarter of 2024. Curaleaf's CEO, Matt Darin, highlighted the company's focus
Curaleaf Narrows 2Q Loss as Sales Edge Higher
By Dean Seal Curaleaf Holdings narrowed its loss in the first quarter as sales in its retail and wholesale channels ticked higher. The largest U.S. cannabis company by revenue posted a loss of $48.3
Press Release: Curaleaf Reports First Quarter 2024 Results
Curaleaf Reports First Quarter 2024 Results Canada NewsWire NEW YORK, May 9, 2024 First quarter 2024 revenue of $339 million, representing an increase of 2% year-over-year and adjusted gross margin
Analysis
Price Target
No Data
